Recent Advances in Nanoparticle Carriers for Coordination Complexes

Author(s): Mariana Rillo Sato, Patricia Bento da Silva, Rodrigo Alves de Souza, Karen Cristina dos Santos, Marlus Chorilli

Journal Name: Current Topics in Medicinal Chemistry

Volume 15 , Issue 4 , 2015

Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Coordination compounds are substances in which a central metal atom is bonded to nonmetal atoms, or groups of atoms, called ligands. Examples include vitamin B12, hemoglobin, chlorophyll, dyes and pigments, as well as catalysts used in organic synthesis. Coordination compounds have received much attention in recent years. This interest was prompted by the discovery that several coordination compounds exhibit activity against bacteria, fungi and cancer. Some coordination compounds are not in clinical use, because of poor water solubility. Because they are unable to cross the lipid membranes of cells, bioavailability and efficacy are low. Some researchers have applied nanotechnology to coordination compounds, hoping to reduce the number of doses required and the severity of side effects, and also to improve biological activity. Nanotechnology can deliver active components in sufficient concentrations throughout treatment, guiding it to the desired location of action; conventional treatments do not meet these requirements. In this study we review some drug delivery systems based on nanotechnology, such as microemulsions (MEs), cyclodextrin (CD), polymeric nanoparticles (PN), solid lipid nanoparticles (SLNs), nanostructured lipid carriers (NLCs), magnetic and gold nanoparticles (MNPs / AuNPs) and liquid crystalline systems (LC), and coordination compounds.

Keywords: Biological activity, Coordination compound, Drug delivery systems, Metallic complex, Nanosystems, Nanotechnology.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2015
Published on: 10 February, 2015
Page: [287 - 297]
Pages: 11
DOI: 10.2174/1568026615666150108145614
Price: $65

Article Metrics

PDF: 44